$0.38 0.02 (+5.92%)
2/10/2012 4:00 PM

CytRx Corp (NASDAQ:CYTR)

CAPS Rating: 2 out of 5

A biopharmaceutical research and development company engaged in developing human therapeutic products based primarily upon its small molecule molecular chaperone co-induction technology.

Featured Broker Partners


Advertisement